
Hindustan Zinc Q1 Results: Vedanta arm reports 4.7% drop in net profit to ₹2,234 crore, revenue down 4.4% YoY
Vedanta-owned zinc producer's consolidated revenue from operations stood at ₹ 7,771 crores during the quarter ended June from ₹ 8,130 crore in Q1FY25, a year-on-year fall of 4.4%. Sequentially, the revenue slipped 14.5% from ₹ 9,087 crore in Q4FY25.
The decline in revenue was attributed by the company to reduced volumes and decreased prices for zinc and lead commodities, although this was somewhat compensated by increased silver prices, a stronger dollar, and better by-product realisations.
In its filing to the exchange, the company reported an EBITDA of ₹ 3,860 crores, a decrease of 2% year-over-year, primarily due to reduced volumes and declining prices for zinc and lead, although this was somewhat balanced by rising silver prices, a stronger dollar, and reduced production costs. The company achieved an industry-leading EBITDA margin of approximately 50%.
Additionally, the company reported that it achieved its lowest first-quarter zinc cost of production since the transition to underground operations, recorded at US$ 1,010 per tonne, reflecting a 9% year-over-year improvement due to enhanced metal grades, increased usage of domestic coal and renewable energy, higher revenues from by-products, and reduced input commodity prices, with some reduction in volume offsetting these gains.
As of June 30, 2025, the company maintained substantial gross investments and cash, along with cash equivalents totaling ₹ 9,340 crores invested in high-quality debt instruments. The total borrowings that remained outstanding on June 30, 2025, amounted to ₹ 13,524 crores.
"Delivering our highest-ever first quarter mined metal production at the lowest-ever zinc cost of production reflects our relentless focus on operational efficiencies and cost leadership.
In line with the rising zinc demand projected by 2030, the Board has approved the Phase-1 expansion project towards 2x growth, further strengthening our growth pipeline. Coupled with the addition of blocks of critical minerals and rare earth elements, we are strategically poised to transform into a true multi-metal powerhouse, unlocking sustained value for all our stakeholders," said Arun Misra, Chief Executive Officer (CEO) of the company.
The company's board of directors declared an interim dividend of ₹ 10 per equity share on June 11, 2025, totaling ₹ 4,225 Crore, with the record date set for June 17, 2025, for the financial year 2025-26.
'Staying true to our commitment to create long-term value for our shareholders, the Board declared an interim dividend of ₹ 10 per share during the quarter, reinforcing our track record of consistent returns. Amidst continued global uncertainties, our healthy balance sheet, structurally leaner cost base, and robust growth project pipeline position us well to deliver sustainable long-term value,' said Sandeep Modi, Chief Financial Officer (CFO) of the company.
Hindustan Zinc share price today opened at ₹ 440.65 apiece on the BSE, the stock touched an intraday high of ₹ 441.45 apiece, and an intraday low of ₹ 431.45 per share.
According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, Hindustan Zinc share prices are trading with marginal cuts post the result announcement, Overall the prices have struggled in the last 4 sessions to cross the 20DEMA, Going ahead positive momentum would trigger only when prices surpass this key support around ₹ 445 , until then prices could dip towards recent swing low of ₹ 415.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
18 minutes ago
- Economic Times
Uber in talks with banks, private equity firms to fund robotaxi expansion
Synopsis The company has been offering robotaxis from Alphabet-owned Waymo on its ride-hailing app in Austin and Atlanta. It also struck a $300 million partnership in July that will allow it to deploy more than 20,000 vehicles.

Hindustan Times
an hour ago
- Hindustan Times
Brazil's President Lula plans joint statement with PM Narendra Modi, other BRICS leaders on Donald Trump's tariffs
Brazilian President Luiz Inacio Lula da Silva on Wednesday indicated his plans to call PM Narendra Modi and other leaders of the BRICS bloc in response to the tariffs imposed by US President Donald Trump. Brazil's President Luiz Inacio Lula da Silva speaks during an interview with Reuters at the Alvorada Palace, in Brasilia, Brazil, He said he was planning to ring PM Narendra Modi, Chinese President Xi Jinping and other leaders of BRICS.(REUTERS) The US tariffs on Brazilian goods jumped to 50% on Wednesday, but Lula said that his country won't announce any reciprocal measures. Instead, the Brazilian President told Reuters in an interview that he was planning to ring PM Narendra Modi, Chinese President Xi Jinping and other leaders of BRICS to discuss the possibility of a joint statement on Trump's tariffs. Trump had announced that the US would impose an additional 10 per cent tariff on 'any country aligning themselves with the Anti-American policies of BRICS' with 'no exceptions'. The BRICS countries, including India, had released a joint declaration voicing 'serious concerns' about the 'rise of unilateral tariff and non-tariff measures' in an apparent jibe at the Trump administration's trade policy. Lula might be looking for a more stinging statement from BRICS this time around. Brazil President doubles down on not calling Donald Trump Brazil's President Luiz Inacio Lula da Silva is in no rush to ring the White House, doubling down on his earlier statement that he wouldn't call Donald Trump to hold talks over the tariff issue. "The day my intuition says Trump is ready to talk, I won't hesitate to call him. But today my intuition says he doesn't want to talk. And I'm not going to humiliate myself," Lula told Reuters. Lula described the US-Brazil relations at a 200-year nadir after Trump tied the new tariff to his demand for an end to the prosecution of right-wing former President Jair Bolsonaro, who is standing trial for plotting to overturn the 2022 election. The President said Brazil's Supreme Court, which is hearing the case against Bolsonaro, "does not care what Trump says and it should not," adding that Bolsonaro should face another trial for provoking Trump's intervention, calling the right-wing former president a "traitor to the homeland." "We had already pardoned the US intervention in the 1964 coup. But this now is not a small intervention. It's the president of the United States thinking he can dictate rules for a sovereign country like Brazil. It's unacceptable," Lula said. Despite Brazil's exports facing one of the highest tariffs imposed by Trump, the new US trade barriers look unlikely to derail Latin America's largest economy, giving its President more room to stand his ground against Trump than most Western leaders.


Time of India
an hour ago
- Time of India
Agilent opens new biopharma centre in Hyd
Hyderabad: US-based analytical and clinical laboratory technologies player Agilent Technologies Inc has opened its new biopharma experience centre in Hyderabad. The facility will offer advanced laboratory technologies, expert training, and regulatory-ready workflows to expedite the development of high-quality, life-saving medicines. It will provide comprehensive solutions in chromatography, mass spectrometry, cell analysis, and lab informatics, enabling companies to simulate real lab environments and develop market-ready solutions, Agilent said. The new centre will also drive collaboration between industry and academia, support faster R&D, and align with international regulatory standards. Inaugurating the new facility on Tuesday, Telangana IT and industries minister Duddila Sridhar Babu said the centre will bolster Hyderabad's position as a leader in life sciences and healthcare innovation. He said Hyderabad's robust life sciences ecosystem contributes to nearly one-third of India's pharmaceutical production and 40% of bulk drug exports. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad Agilent Technologies CEO Padraig McDonnell said: "India is a strategic growth market for Agilent, and Hyderabad is at the forefront of biopharma innovation. This new centre reflects our commitment to delivering integrated solutions that help bring life-changing therapies to market faster and more efficiently. It also reinforces our support for the 'Make-in-India' initiative by empowering local innovation, nurturing talent, and enabling scalable, affordable, and sustainable solutions. " He said the investment is part of the company's broader strategy to expand its footprint in India and position it as a strategic hub in its global innovation roadmap.